CP and COVID-19: CP therapy may confer benefits through various mechanisms, including the direct neutralization of SARS-CoV-2, enhancement of antibody-dependent cellular cytotoxicity (ADCC), and modulation of excessive inflammation, often a key driver of severe COVID-19 complications [12, 13].